
Panos Chrysanthopoulos, PhD
Co-founder & Director

Cell & gene therapy development
CMC strategy and preclinical development, supported by process, analytical, and hands-on expertise for the journey to the clinic.
Expertise, connected
Cell and gene therapy development brings complex questions. We connect the scientific, technical, and operational expertise to help you answer them.
Explore all servicesConnect product requirements and CMC planning with preclinical development, including model selection, IND-enabling study design, and CRO selection and management.
Develop a deeper understanding of the process and the analytical methods that support product characterization.
Bring structure to technology transfer, operating practices, and the selection and oversight of development partners.
Use QbD, experimental design, and laboratory studies to identify what matters and inform the next development decision.
Our approach
A connected approach to product development, with the right questions, purposeful experiments, and evidence to guide each step.
Define product goals, map development gaps, and identify the decisions ahead.
Connect risk assessment, DoE, and analytics to investigate the factors that matter.
Align processes, methods, materials, and partners around a practical execution plan.
Use process characterization and comparability to support informed development decisions.
Wet lab services
Practical laboratory expertise brings development plans into the experiment. Connect your strategy with the studies needed to move it forward.
Explore our lab capabilitiesThe people behind the science
Scientists and development leaders who bring complementary expertise to the challenges of cell and gene therapy.
Meet the full team
Co-founder & Director

Co-founder & Director

Senior Partner & Head of Business Development
Perspectives & resources
Expert workshop
A discussion of the development considerations that connect early concepts to clinical products and beyond.
Explore the workshopIndustry perspective
Insights from a voice-of-customer survey exploring the priorities of cell and gene therapy developers.
Explore the findingsYour next development decision
Bring us your questions. We’ll help define the next steps.